Literature DB >> 20120394

[Crenobalneotherapy: a medical and scientific update].

Christian-François Roques1, Xavier de Boissezon, Patrice Queneau.   

Abstract

The PubMed database contains about eighty scientific papers on crenobalneotherapy (i.e., medical balneology or spa therapy) published in the last three years, mostly in journals with an impact factor. These studies focus on the actions of thermomineral products (waters, muds, gases, steam) on biological systems (immune system, antioxidant system, cytokine networks, nociception, etc.). Hot mineral waters can have an action on the circulatory system. Ingested mineral water can act on carbohydrate, lipid and mineral metabolism. Dermocosmetologic mineral products have shown real benefits. Medical benefits of thermal treatment have been observed in patients with rheumatic conditions, psoriasis, venous insufficiency, ENT conditions, gynecolgical disorders, and anxiety. Unfortunately, many publications in this area suffer from methodological flaws. Clinical investigations of thermal medicine encounter dificulties of a methodological and financial nature, and problems of patient recruitment. The aim of the French thermal research institute is to provide support and advice for teams wishing to conduct well-designed controlled trials.

Entities:  

Mesh:

Year:  2009        PMID: 20120394

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  2 in total

1.  Is thalassotherapy simply a type of climatotherapy?

Authors:  Francisco Maraver; Alfredo Michán; Carla Morer; Lourdes Aguilera
Journal:  Int J Biometeorol       Date:  2010-10-31       Impact factor: 3.787

2.  Evaluation of the efficacy of a short-course, personalized self-management and intensive spa therapy intervention as active prevention of musculoskeletal disorders of the upper extremities (Muska): a research protocol for a randomized controlled trial.

Authors:  Charlotte Lanhers; Bruno Pereira; Chloé Gay; Christian Hérisson; Christine Levyckyj; Arnaud Dupeyron; Emmanuel Coudeyre
Journal:  BMC Musculoskelet Disord       Date:  2016-12-09       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.